Zentalis Pharmaceuticals, Inc.
SEC Filing List
ZNTL CIK: 0001725160
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 07/30/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Skvarka Jan | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | |
| 4 | Statement of changes in beneficial owner... | Johnson David Michael | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | |
| 4 | Statement of changes in beneficial owner... | Kariuki Enoch | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | |
| 4 | Statement of changes in beneficial owner... | Myers Scott Dunseth | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | |
| 4 | Statement of changes in beneficial owner... | Walker Luke Nathaniel | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | |
| 8-K | Current report filing | Zentalis Pharmaceuticals, Inc. | 06/18/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Campbell Shannon | Zentalis Pharmaceuticals, Inc. | 05/27/2026 | |
| 4 | Statement of changes in beneficial owner... | Campbell Shannon | Zentalis Pharmaceuticals, Inc. | 05/27/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Zentalis Pharmaceuticals, Inc. | 05/27/2026 | ||
| No record found. | |||||
| Load More | |||||
